Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 629839Generated: October 30, 2026

Buprenorphine component OF alks-5461 → 7alpha-[(2S)-3,3-dimethyl-2-hydroxybutan-2-yl]-4,5alpha-epoxy-3,6-dihydroxy-17-methyl-6alpha,14alpha-ethanomorphinan

https://huagongshe.com/reaction/629839

Reaction equation

Participants

RoleNameHCIDCharge
ReactantBuprenorphine component OF alks-5461HCID 9848990—
Reactant17-cyclopropylmethyl-7alpha-[(2S)-3,3-dimethyl-2-hydroxybutan-2-yl]-4,5alpha-epoxy-3,6-dihydroxy-6alpha,14alpha-ethanomorphinanHCID 86711659—
Product7alpha-[(2S)-3,3-dimethyl-2-hydroxybutan-2-yl]-4,5alpha-epoxy-3,6-dihydroxy-17-methyl-6alpha,14alpha-ethanomorphinanHCID 8671166682.5%

Reaction Steps

Compound 21 was synthesized similar to the procedure described in Example 1 for the preparation of compound 2 using compound 20 rather than compound 1. After isolation, 3.76 g of compound 21 (82.5%) was obtained with a purity of 92.7% as an off-white solid A sample was further purified by column chromatography to afford compound 21 in >99% purity as a white solid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09315514B2
Source datasetuspto-grants-2016_04
ORD IDord-6923c86e02c0440fb666a0c68ae0e7a3
Source noteuspto-grants-2016_04